X-18628470-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001323289.2(CDKL5):c.2596C>T(p.Gln866*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001323289.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.2596C>T | p.Gln866* | stop_gained | Exon 18 of 18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.2596C>T | p.Gln866* | stop_gained | Exon 19 of 22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.2596C>T | p.Gln866* | stop_gained | Exon 18 of 21 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.2596C>T | p.Gln866* | stop_gained | Exon 18 of 18 | 1 | NM_001323289.2 | ENSP00000485244.1 | ||
CDKL5 | ENST00000379989.6 | c.2596C>T | p.Gln866* | stop_gained | Exon 19 of 22 | 1 | ENSP00000369325.3 | |||
CDKL5 | ENST00000379996.7 | c.2596C>T | p.Gln866* | stop_gained | Exon 18 of 21 | 1 | ENSP00000369332.3 | |||
CDKL5 | ENST00000674046.1 | c.2719C>T | p.Gln907* | stop_gained | Exon 19 of 19 | ENSP00000501174.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 2 Pathogenic:1
- -
not provided Pathogenic:1
The Gln866Stop nonsense mutation in the CDKL5 gene is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in EPILEPSY panel(s). -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln866*) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with CDKL5-related conditions (PMID: 29655203). ClinVar contains an entry for this variant (Variation ID: 156691). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at